INS and metabolic disease: An imbalance in insulin signaling can drive metabolic disease due to its activity as a regulator of cellular metabolic homeostasis [31] and our unbiased proteomic analyses further revealed significant changes in key downstream mediators of the transcriptional response to insulin signaling that are central to metabolic homeostasis.